Fidelity Investments’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Sell |
5,719,758
-298,261
| -5% | -$1.07M | ﹤0.01% | 1688 |
|
|
2025
Q1 | $18M | Sell |
6,018,019
-407,206
| -6% | -$1.22M | ﹤0.01% | 1715 |
|
|
2024
Q4 | $21.5M | Sell |
6,425,225
-193,072
| -3% | -$647K | ﹤0.01% | 1700 |
|
|
2024
Q3 | $22.2M | Buy |
6,618,297
+182,174
| +3% | +$610K | ﹤0.01% | 1673 |
|
|
2024
Q2 | $21.3M | Buy |
6,436,123
+657,094
| +11% | +$2.17M | ﹤0.01% | 1622 |
|
|
2024
Q1 | $23.3M | Buy |
5,779,029
+428,370
| +8% | +$1.73M | ﹤0.01% | 1590 |
|
|
2023
Q4 | $16.3M | Sell |
5,350,659
-1,101,891
| -17% | -$3.36M | ﹤0.01% | 1692 |
|
|
2023
Q3 | $19.4M | Sell |
6,452,550
-2,044,756
| -24% | -$6.13M | ﹤0.01% | 1591 |
|
|
2023
Q2 | $31.8M | Sell |
8,497,306
-3,076,073
| -27% | -$11.5M | ﹤0.01% | 1440 |
|
|
2023
Q1 | $38.8M | Sell |
11,573,379
-164,030
| -1% | -$550K | ﹤0.01% | 1353 |
|
|
2022
Q4 | $56.5M | Sell |
11,737,409
-751,337
| -6% | -$3.61M | 0.01% | 1213 |
|
|
2022
Q3 | $71.1M | Sell |
12,488,746
-50,729
| -0.4% | -$289K | 0.01% | 1089 |
|
|
2022
Q2 | $89M | Sell |
12,539,475
-40,316
| -0.3% | -$286K | 0.01% | 1021 |
|
|
2022
Q1 | $90.8M | Buy |
12,579,791
+114,382
| +0.9% | +$826K | 0.01% | 1106 |
|
|
2021
Q4 | $111M | Buy |
12,465,409
+48,876
| +0.4% | +$437K | 0.01% | 1056 |
|
|
2021
Q3 | $435M | Buy |
12,416,533
+6,003
| +0% | +$210K | 0.03% | 480 |
|
|
2021
Q2 | $267M | Buy |
12,410,530
+1,651,735
| +15% | +$35.5M | 0.02% | 697 |
|
|
2021
Q1 | $664M | Buy |
10,758,795
+4,311,103
| +67% | +$266M | 0.06% | 330 |
|
|
2020
Q4 | $269M | Buy |
+6,447,692
| New | +$269M | 0.02% | 628 |
|